-
1
-
-
77954345275
-
Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
Oberg K, Hellman P, Kwekkeboom D, Jelic S. Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5):v220-222.
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 5
-
-
Oberg, K.1
Hellman, P.2
Kwekkeboom, D.3
Jelic, S.4
-
2
-
-
33750603100
-
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database
-
Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-4544.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4539-4544
-
-
Govindan, R.1
Page, N.2
Morgensztern, D.3
-
3
-
-
33846013518
-
Temporal trends in small cell lung cancer: Analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database [abstract]
-
Abstract 7082
-
Navada S, Lai P, Schwartz A, Kalemkerian G. Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database [abstract]. J Clin Oncol 2006;24(Suppl 18):Abstract 7082.
-
(2006)
J Clin Oncol
, vol.24
, Issue.SUPPL. 18
-
-
Navada, S.1
Lai, P.2
Schwartz, A.3
Kalemkerian, G.4
-
5
-
-
33947582831
-
A review of first-line treatment for small-cell lung cancer
-
Murray N, Turrisi AT III. A review of first-line treatment for small-cell lung cancer. J Thorac Oncol 2006;1:270-278.
-
(2006)
J Thorac Oncol
, vol.1
, pp. 270-278
-
-
Murray, N.1
Turrisi III, A.T.2
-
6
-
-
58049101796
-
Management of small-cell lung cancer: Incremental changes but hope for the future
-
Williston Park
-
Hann CL, Rudin CM. Management of small-cell lung cancer: incremental changes but hope for the future. Oncology (Williston Park) 2008;22:1486-1492.
-
(2008)
Oncology
, vol.22
, pp. 1486-1492
-
-
Hann, C.L.1
Rudin, C.M.2
-
7
-
-
1942471677
-
Basic treatment considerations using chemotherapy for patients with small cell lung cancer
-
Johnson BE, Janne PA. Basic treatment considerations using chemotherapy for patients with small cell lung cancer. Hematol Oncol Clin North Am 2004;18:309-322.
-
(2004)
Hematol Oncol Clin North Am
, vol.18
, pp. 309-322
-
-
Johnson, B.E.1
Janne, P.A.2
-
8
-
-
75149169449
-
Treatment of extensive-stage small cell lung carcinoma: Current status and future prospects
-
Demedts IK, Vermaelen KY, van Meerbeeck JP. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur Respir J 2010;35:202-215.
-
(2010)
Eur Respir J
, vol.35
, pp. 202-215
-
-
Demedts, I.K.1
Vermaelen, K.Y.2
Van Meerbeeck, J.P.3
-
9
-
-
0037504527
-
Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival
-
Videtic GM, Stitt LW, Dar AR, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003;21:1544-1549.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1544-1549
-
-
Videtic, G.M.1
Stitt, L.W.2
Dar, A.R.3
-
10
-
-
0037328006
-
Pathology of small cell carcinoma of the lung
-
Zakowski MF. Pathology of small cell carcinoma of the lung. Semin Oncol 2003;30:3-8.
-
(2003)
Semin Oncol
, vol.30
, pp. 3-8
-
-
Zakowski, M.F.1
-
12
-
-
0030961496
-
Extrapulmonary small cell carcinoma
-
Galanis E, Frytak S, Lloyd RV. Extrapulmonary small cell carcinoma. Cancer 1997;79:1729-1736.
-
(1997)
Cancer
, vol.79
, pp. 1729-1736
-
-
Galanis, E.1
Frytak, S.2
Lloyd, R.V.3
-
13
-
-
0026747929
-
Extrapulmonary and pulmonary small-cell carcinoma: Tumor biology, therapy, and outcome
-
Remick SC, Ruckdeschel JC. Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome. Med Pediatr Oncol 1992;20:89-99.
-
(1992)
Med Pediatr Oncol
, vol.20
, pp. 89-99
-
-
Remick, S.C.1
Ruckdeschel, J.C.2
-
14
-
-
0024386775
-
Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies
-
Johnson BE, Whang-Peng J, Naylor SL, et al. Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. J Natl Cancer Inst 1989;81:1223-1228.
-
(1989)
J Natl Cancer Inst
, vol.81
, pp. 1223-1228
-
-
Johnson, B.E.1
Whang-Peng, J.2
Naylor, S.L.3
-
15
-
-
0028073366
-
The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies
-
Guinee DG Jr, Fishback NF, Koss MN, et al. The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. Am J Clin Pathol 1994;102:406-414.
-
(1994)
Am J Clin Pathol
, vol.102
, pp. 406-414
-
-
Guinee Jr., D.G.1
Fishback, N.F.2
Koss, M.N.3
-
16
-
-
78649390219
-
Advances in neuroendocrine lung tumors
-
Travis WD. Advances in neuroendocrine lung tumors. Ann Oncol 2010;21(Suppl 7):vii65-71.
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 7
-
-
Travis, W.D.1
-
17
-
-
47149104096
-
Bronchopulmonary neuroendocrine tumors
-
Gustafsson BI, Kidd M, Chan A, et al. Bronchopulmonary neuroendocrine tumors. Cancer 2008;113:5-21.
-
(2008)
Cancer
, vol.113
, pp. 5-21
-
-
Gustafsson, B.I.1
Kidd, M.2
Chan, A.3
-
18
-
-
18144369998
-
Distinguishing carcinoid tumor from small cell carcinoma of the lung: Correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program
-
Renshaw AA, Haja J, Lozano RL, Wilbur DC. Distinguishing carcinoid tumor from small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med 2005;129:614-618.
-
(2005)
Arch Pathol Lab Med
, vol.129
, pp. 614-618
-
-
Renshaw, A.A.1
Haja, J.2
Lozano, R.L.3
Wilbur, D.C.4
-
19
-
-
79961108629
-
Reduced lung-cancer mortality with low-dose computed tomographic screening
-
Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
-
(2011)
N Engl J Med
, vol.365
, pp. 395-409
-
-
Aberle, D.R.1
Adams, A.M.2
Berg, C.D.3
-
20
-
-
79953008247
-
Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers
-
Cuffe S, Moua T, Summerfield R, et al. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol 2011;6:818-822.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 818-822
-
-
Cuffe, S.1
Moua, T.2
Summerfield, R.3
-
21
-
-
33747602338
-
Paraneoplastic syndromes associated with small cell lung cancer
-
Gandhi L, Johnson BE. Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Canc Netw 2006;4:631-638.
-
(2006)
J Natl Compr Canc Netw
, vol.4
, pp. 631-638
-
-
Gandhi, L.1
Johnson, B.E.2
-
22
-
-
79953119082
-
Small-cell lung cancer-associated autoantibodies: Potential applications to cancer diagnosis, early detection, and therapy
-
Kazarian M, Laird-Offringa IA. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer 2011;10:33.
-
(2011)
Mol Cancer
, vol.10
, pp. 33
-
-
Kazarian, M.1
Laird-Offringa, I.A.2
-
23
-
-
0031017013
-
Paraneoplastic syndromes associated with small cell lung cancer
-
Marchioli CC, Graziano SL. Paraneoplastic syndromes associated with small cell lung cancer. Chest Surg Clin N Am 1997;7:65-80.
-
(1997)
Chest Surg Clin N Am
, vol.7
, pp. 65-80
-
-
Marchioli, C.C.1
Graziano, S.L.2
-
24
-
-
52049103838
-
Screening for small-cell lung cancer: A follow-up study of patients with Lambert-Eaton myasthenic syndrome
-
Titulaer MJ, Wirtz PW, Willems LN, et al. Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome. J Clin Oncol 2008;26:4276-4281.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4276-4281
-
-
Titulaer, M.J.1
Wirtz, P.W.2
Willems, L.N.3
-
25
-
-
0029811225
-
Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma
-
Meriney SD, Hulsizer SC, Lennon VA, Grinnell AD. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann Neurol 1996;40:739-749.
-
(1996)
Ann Neurol
, vol.40
, pp. 739-749
-
-
Meriney, S.D.1
Hulsizer, S.C.2
Lennon, V.A.3
Grinnell, A.D.4
-
26
-
-
0034981452
-
Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of 200 patients
-
Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124:1138-1148.
-
(2001)
Brain
, vol.124
, pp. 1138-1148
-
-
Graus, F.1
Keime-Guibert, F.2
Rene, R.3
-
27
-
-
0027461249
-
Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications
-
Delisle L, Boyer MJ, Warr D, et al. Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med 1993;153:746-752.
-
(1993)
Arch Intern Med
, vol.153
, pp. 746-752
-
-
Delisle, L.1
Boyer, M.J.2
Warr, D.3
-
28
-
-
0030687945
-
A prospective study of patients with lung cancer and hyponatremia of malignancy
-
Johnson BE, Chute JP, Rushin J, et al. A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 1997;156:1669-1678.
-
(1997)
Am J Respir Crit Care Med
, vol.156
, pp. 1669-1678
-
-
Johnson, B.E.1
Chute, J.P.2
Rushin, J.3
-
29
-
-
84862846656
-
Diagnosis and management of hyponatremia in cancer patients
-
Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist 2012;17:756-765.
-
(2012)
Oncologist
, vol.17
, pp. 756-765
-
-
Castillo, J.J.1
Vincent, M.2
Justice, E.3
-
30
-
-
77956383370
-
Paraneoplastic syndromes: An approach to diagnosis and treatment
-
Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 2010;85:838-854.
-
(2010)
Mayo Clin Proc
, vol.85
, pp. 838-854
-
-
Pelosof, L.C.1
Gerber, D.E.2
-
31
-
-
33751005260
-
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
-
Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099-2112.
-
(2006)
N Engl J Med
, vol.355
, pp. 2099-2112
-
-
Schrier, R.W.1
Gross, P.2
Gheorghiade, M.3
-
32
-
-
45349106231
-
Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: Subgroup analysis of a randomized, controlled study
-
Verbalis JG, Zeltser D, Smith N, et al. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study. Clin Endocrinol (Oxf) 2008;69:159-168.
-
(2008)
Clin Endocrinol (Oxf)
, vol.69
, pp. 159-168
-
-
Verbalis, J.G.1
Zeltser, D.2
Smith, N.3
-
33
-
-
0036753654
-
Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease?
-
Micke P, Faldum A, Metz T, et al. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease? Lung Cancer 2002;37:271-276.
-
(2002)
Lung Cancer
, vol.37
, pp. 271-276
-
-
Micke, P.1
Faldum, A.2
Metz, T.3
-
34
-
-
84860317809
-
Staging and imaging of small cell lung cancer
-
Kalemkerian GP. Staging and imaging of small cell lung cancer. Cancer Imaging 2011;11:253-258.
-
(2011)
Cancer Imaging
, vol.11
, pp. 253-258
-
-
Kalemkerian, G.P.1
-
35
-
-
37349068491
-
The International Association for the Study of Lung Cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer
-
Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007;2:1067-1077.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 1067-1077
-
-
Shepherd, F.A.1
Crowley, J.2
Van Houtte, P.3
-
36
-
-
67049161492
-
The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition
-
Ignatius Ou SH, Zell JA. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition. J Thorac Oncol 2009;4:300-310.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 300-310
-
-
Ignatius Ou, S.H.1
Zell, J.A.2
-
37
-
-
69549097677
-
The IASLC Lung Cancer Staging Project: Proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer
-
Vallieres E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:1049-1059.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 1049-1059
-
-
Vallieres, E.1
Shepherd, F.A.2
Crowley, J.3
-
38
-
-
64249099411
-
-
7th Ed, New York, NY: Springer
-
Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer; 2010.
-
(2010)
AJCC Cancer Staging Manual
-
-
Edge, S.B.1
Byrd, D.R.2
Compton, C.C.3
-
39
-
-
34548457234
-
The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
-
Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 706-714
-
-
Goldstraw, P.1
Crowley, J.2
Chansky, K.3
-
40
-
-
67650436288
-
NCCN task force: Clinical utility of PET in a variety of tumor types
-
Podoloff DA, Ball DW, Ben-Josef E, et al. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw 2009;7(Suppl 2):S1-26.
-
(2009)
J Natl Compr Canc Netw
, vol.7
, Issue.SUPPL. 2
-
-
Podoloff, D.A.1
Ball, D.W.2
Ben-Josef, E.3
-
41
-
-
4344626094
-
Positron emission tomography in limited-stage small-cell lung cancer: A prospective study
-
Bradley JD, Dehdashti F, Mintun MA, et al. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 2004;22:3248-3254.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3248-3254
-
-
Bradley, J.D.1
Dehdashti, F.2
Mintun, M.A.3
-
42
-
-
33846844826
-
18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)
-
18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). Am J Clin Oncol 2007;30:45-50.
-
(2007)
Am J Clin Oncol
, vol.30
, pp. 45-50
-
-
Kut, V.1
Spies, W.2
Spies, S.3
-
43
-
-
78149277688
-
High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer
-
Azad A, Chionh F, Scott AM, et al. High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer. Mol Imaging Biol 2010;12:443-451.
-
(2010)
Mol Imaging Biol
, vol.12
, pp. 443-451
-
-
Azad, A.1
Chionh, F.2
Scott, A.M.3
-
44
-
-
33847259140
-
A prospective study of PET/CT in initial staging of small-cell lung cancer: Comparison with CT, bone scintigraphy and bone marrow analysis
-
Fischer BM, Mortensen J, Langer SW, et al. A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol 2007;18:338-345.
-
(2007)
Ann Oncol
, vol.18
, pp. 338-345
-
-
Fischer, B.M.1
Mortensen, J.2
Langer, S.W.3
-
45
-
-
19944428215
-
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer
-
Brink I, Schumacher T, Mix M, et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004;31:1614-1620.
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, pp. 1614-1620
-
-
Brink, I.1
Schumacher, T.2
Mix, M.3
-
46
-
-
1542787390
-
Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer
-
Kamel EM, Zwahlen D, Wyss MT, et al. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003;44:1911-1917.
-
(2003)
J Nucl Med
, vol.44
, pp. 1911-1917
-
-
Kamel, E.M.1
Zwahlen, D.2
Wyss, M.T.3
-
47
-
-
39149131711
-
Can positron emission tomography be used as a staging tool for small-cell lung cancer?
-
Vinjamuri M, Craig M, Campbell-Fontaine A, et al. Can positron emission tomography be used as a staging tool for small-cell lung cancer? Clin Lung Cancer 2008;9:30-34.
-
(2008)
Clin Lung Cancer
, vol.9
, pp. 30-34
-
-
Vinjamuri, M.1
Craig, M.2
Campbell-Fontaine, A.3
-
48
-
-
67649184760
-
Prognostic factors differ by tumor stage for small cell lung cancer: A pooled analysis of North Central Cancer Treatment Group trials
-
Foster NR, Mandrekar SJ, Schild SE, et al. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer 2009;115:2721-2731.
-
(2009)
Cancer
, vol.115
, pp. 2721-2731
-
-
Foster, N.R.1
Mandrekar, S.J.2
Schild, S.E.3
-
49
-
-
0025003393
-
Determinants of improved outcome in small-cell lung cancer: An analysis of the 2,580-patient Southwest Oncology Group data base
-
Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 1990;8:1563-1574.
-
(1990)
J Clin Oncol
, vol.8
, pp. 1563-1574
-
-
Albain, K.S.1
Crowley, J.J.2
Leblanc, M.3
Livingston, R.B.4
-
50
-
-
0034059515
-
Predictive and prognostic factors in small cell lung cancer: Current status
-
Yip D, Harper PG. Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer 2000;28:173-185.
-
(2000)
Lung Cancer
, vol.28
, pp. 173-185
-
-
Yip, D.1
Harper, P.G.2
-
51
-
-
0031906013
-
Brain-only metastases of small cell lung cancer; Efficacy of whole brain radiotherapy. An EORTC phase II study
-
Postmus PE, Haaxma-Reiche H, Gregor A, et al. Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol 1998;46:29-32.
-
(1998)
Radiother Oncol
, vol.46
, pp. 29-32
-
-
Postmus, P.E.1
Haaxma-Reiche, H.2
Gregor, A.3
-
53
-
-
0345872083
-
Multidisciplinary management of lung cancer
-
Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-392.
-
(2004)
N Engl J Med
, vol.350
, pp. 379-392
-
-
Spira, A.1
Ettinger, D.S.2
-
54
-
-
0036197829
-
Management of small cell lung cancer
-
Johnson BE. Management of small cell lung cancer. Clin Chest Med 2002;23:225-239.
-
(2002)
Clin Chest Med
, vol.23
, pp. 225-239
-
-
Johnson, B.E.1
-
55
-
-
0022409779
-
VP-16 and cisplatin as first-line therapy for small-cell lung cancer
-
Evans WK, Shepherd FA, Feld R, et al. VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol 1985;3:1471-1477.
-
(1985)
J Clin Oncol
, vol.3
, pp. 1471-1477
-
-
Evans, W.K.1
Shepherd, F.A.2
Feld, R.3
-
56
-
-
26644438582
-
Small-cell lung cancer
-
Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385-1396.
-
(2005)
Lancet
, vol.366
, pp. 1385-1396
-
-
Jackman, D.M.1
Johnson, B.E.2
-
57
-
-
0037115426
-
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 years' follow-up
-
Sundstrom S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol 2002;20:4665-4672.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4665-4672
-
-
Sundstrom, S.1
Bremnes, R.M.2
Kaasa, S.3
-
58
-
-
0023472047
-
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer
-
Bishop JF, Raghavan D, Stuart-Harris R, et al. Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer. J Clin Oncol 1987;5:1574-1578.
-
(1987)
J Clin Oncol
, vol.5
, pp. 1574-1578
-
-
Bishop, J.F.1
Raghavan, D.2
Stuart-Harris, R.3
-
59
-
-
0027992052
-
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study
-
Skarlos DV, Samantas E, Kosmidis P, et al. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study. Ann Oncol 1994;5:601-607.
-
(1994)
Ann Oncol
, vol.5
, pp. 601-607
-
-
Skarlos, D.V.1
Samantas, E.2
Kosmidis, P.3
-
60
-
-
34447329621
-
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
-
Okamoto H, Watanabe K, Kunikane H, et al. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer 2007;97:162-169.
-
(2007)
Br J Cancer
, vol.97
, pp. 162-169
-
-
Okamoto, H.1
Watanabe, K.2
Kunikane, H.3
-
61
-
-
84863752868
-
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: The COCIS meta-analysis of individual patient data
-
Rossi A, Di Maio M, Chiodini P, et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012;30:1692-1698.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1692-1698
-
-
Rossi, A.1
Di Maio, M.2
Chiodini, P.3
-
62
-
-
0037050354
-
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
-
Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85-91.
-
(2002)
N Engl J Med
, vol.346
, pp. 85-91
-
-
Noda, K.1
Nishiwaki, Y.2
Kawahara, M.3
-
63
-
-
66349102227
-
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: Clinical and pharmacogenomic results from SWOG S0124
-
Lara PN Jr, Natale R, Crowley J, et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009;27:2530-2535.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2530-2535
-
-
Lara Jr., P.N.1
Natale, R.2
Crowley, J.3
-
64
-
-
33646447066
-
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer 10.1200/JCO.2005.04.8595
-
Hanna N, Bunn PA Jr, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer 10.1200/JCO.2005.04.8595. J Clin Oncol 2006;24:2038-2043.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2038-2043
-
-
Hanna, N.1
Bunn Jr., P.A.2
Langer, C.3
-
65
-
-
33645327676
-
A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer
-
Schmittel A, Fischer von Weikersthal L, Sebastian M, et al. A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer. Ann Oncol 2006;17:663-667.
-
(2006)
Ann Oncol
, vol.17
, pp. 663-667
-
-
Schmittel, A.1
Fischer Von Weikersthal, L.2
Sebastian, M.3
-
66
-
-
52049104938
-
Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: A randomized phase III trial
-
Hermes A, Bergman B, Bremnes R, et al. Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial. J Clin Oncol 2008;26:4261-4267.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4261-4267
-
-
Hermes, A.1
Bergman, B.2
Bremnes, R.3
-
67
-
-
78650513543
-
Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: Systematic review with meta-analysis
-
Lima JP, dos Santos LV, Sasse EC, et al. Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis. J Thorac Oncol 2010;5:1986-1993.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 1986-1993
-
-
Lima, J.P.1
Dos Santos, L.V.2
Sasse, E.C.3
-
68
-
-
0032998171
-
Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: Perceptible progress
-
Chute JP, Chen T, Feigal E, et al. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol 1999;17:1794-1801.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1794-1801
-
-
Chute, J.P.1
Chen, T.2
Feigal, E.3
-
69
-
-
0029155454
-
Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: A Hoosier Oncology Group study
-
Loehrer PJ Sr, Ansari R, Gonin R, et al. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study. J Clin Oncol 1995;13:2594-2599.
-
(1995)
J Clin Oncol
, vol.13
, pp. 2594-2599
-
-
Loehrer Sr., P.J.1
Ansari, R.2
Gonin, R.3
-
70
-
-
0035925071
-
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: A French Federation of Cancer Institutes multicenter phase III randomized study
-
Pujol JL, Daures JP, Riviere A, et al. Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst 2001;93:300-308.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 300-308
-
-
Pujol, J.L.1
Daures, J.P.2
Riviere, A.3
-
71
-
-
0027081441
-
A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer
-
Miyamoto H, Nakabayashi T, Isobe H, et al. A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer. Oncology 1992;49:431-435.
-
(1992)
Oncology
, vol.49
, pp. 431-435
-
-
Miyamoto, H.1
Nakabayashi, T.2
Isobe, H.3
-
72
-
-
20544455089
-
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B trial 9732
-
Niell HB, Herndon JE II, Miller AA, et al. Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B trial 9732. J Clin Oncol 2005;23:3752-3759.
-
(2005)
J Clin Oncol
, vol.23
, pp. 3752-3759
-
-
Niell, H.B.1
Herndon, J.E.I.I.2
Miller, A.A.3
-
73
-
-
0035871527
-
Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-A phase III trial of the eastern cooperative oncology group
-
Schiller JH, Adak S, Cella D, et al. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-a phase III trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2001;19:2114-2122.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2114-2122
-
-
Schiller, J.H.1
Adak, S.2
Cella, D.3
-
74
-
-
0018569942
-
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
-
Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-1733.
-
(1979)
Cancer Treat Rep
, vol.63
, pp. 1727-1733
-
-
Goldie, J.H.1
Coldman, A.J.2
-
75
-
-
0025898914
-
Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer
-
Fukuoka M, Furuse K, Saijo N, et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 1991;83:855-861.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 855-861
-
-
Fukuoka, M.1
Furuse, K.2
Saijo, N.3
-
76
-
-
0026500785
-
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group
-
Roth BJ, Johnson DH, Einhorn LH, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1992;10:282-291.
-
(1992)
J Clin Oncol
, vol.10
, pp. 282-291
-
-
Roth, B.J.1
Johnson, D.H.2
Einhorn, L.H.3
-
77
-
-
0026033331
-
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer
-
Miles DW, Earl HM, Souhami RL, et al. Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer. J Clin Oncol 1991;9:280-285.
-
(1991)
J Clin Oncol
, vol.9
, pp. 280-285
-
-
Miles, D.W.1
Earl, H.M.2
Souhami, R.L.3
-
78
-
-
0006663223
-
Potential for long-term survival in extensive stage small-cell lung cancer (ESCLC) with CODE chemotherapy and radiotherapy [abstract]
-
Abstract 377
-
Murray N, Gelmon K, Shah A. Potential for long-term survival in extensive stage small-cell lung cancer (ESCLC) with CODE chemotherapy and radiotherapy [abstract]. Lung Cancer 1994;11(Suppl 1):99. Abstract 377.
-
(1994)
Lung Cancer
, vol.11
, Issue.SUPPL. 1
, pp. 99
-
-
Murray, N.1
Gelmon, K.2
Shah, A.3
-
79
-
-
0027488737
-
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: A phase III randomized study conducted by the European Lung Cancer Working Party
-
Sculier JP, Paesmans M, Bureau G, et al. Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party. J Clin Oncol 1993;11:1858-1865.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1858-1865
-
-
Sculier, J.P.1
Paesmans, M.2
Bureau, G.3
-
80
-
-
0027948376
-
Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: A Cancer Research Campaign trial
-
Souhami RL, Rudd R, Ruiz de Elvira MC, et al. Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial. J Clin Oncol 1994;12:1806-1813.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1806-1813
-
-
Souhami, R.L.1
Rudd, R.2
Ruiz De Elvira, M.C.3
-
81
-
-
8044245919
-
CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
-
Fukuoka M, Masuda N, Negoro S, et al. CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. Br J Cancer 1997;75:306-309.
-
(1997)
Br J Cancer
, vol.75
, pp. 306-309
-
-
Fukuoka, M.1
Masuda, N.2
Negoro, S.3
-
82
-
-
0032793437
-
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group
-
Murray N, Livingston RB, Shepherd FA, et al. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol 1999;17:2300-2308.
-
(1999)
J Clin Oncol
, vol.17
, pp. 2300-2308
-
-
Murray, N.1
Livingston, R.B.2
Shepherd, F.A.3
-
83
-
-
0342627241
-
Preclinical models for high-dose therapy
-
In: Armitage JO, Antman KH, eds. Baltimore, MD: Williams and Wilkins, 2nd Ed
-
Teicher BA. Preclinical models for high-dose therapy. In: Armitage JO, Antman KH, eds. High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells, 2nd ed. Baltimore, MD: Williams and Wilkins; 1995:14-42.
-
(1995)
High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells
, pp. 14-42
-
-
Teicher, B.A.1
-
84
-
-
0017701402
-
Intensive chemotherapy of small cell bronchogenic carcinoma
-
Cohen MH, Creaven PJ, Fossieck BE Jr, et al. Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 1977;61:349-354.
-
(1977)
Cancer Treat Rep
, vol.61
, pp. 349-354
-
-
Cohen, M.H.1
Creaven, P.J.2
Fossieck Jr., B.E.3
-
85
-
-
0023610106
-
A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group
-
Johnson DH, Einhorn LH, Birch R, et al. A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1987;5:1731-1738.
-
(1987)
J Clin Oncol
, vol.5
, pp. 1731-1738
-
-
Johnson, D.H.1
Einhorn, L.H.2
Birch, R.3
-
86
-
-
0028149937
-
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
-
Ihde DC, Mulshine JL, Kramer BS, et al. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 1994;12:2022-2034.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2022-2034
-
-
Ihde, D.C.1
Mulshine, J.L.2
Kramer, B.S.3
-
87
-
-
0027521597
-
Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer
-
Arriagada R, Le Chevalier T, Pignon JP, et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993;329:1848-1852.
-
(1993)
N Engl J Med
, vol.329
, pp. 1848-1852
-
-
Arriagada, R.1
Le Chevalier, T.2
Pignon, J.P.3
-
88
-
-
0033963545
-
Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: Results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party
-
Thatcher N, Girling DJ, Hopwood P, et al. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party. J Clin Oncol 2000;18:395-404.
-
(2000)
J Clin Oncol
, vol.18
, pp. 395-404
-
-
Thatcher, N.1
Girling, D.J.2
Hopwood, P.3
-
89
-
-
0025967769
-
Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung
-
Klasa RJ, Murray N, Coldman AJ. Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol 1991;9:499-508.
-
(1991)
J Clin Oncol
, vol.9
, pp. 499-508
-
-
Klasa, R.J.1
Murray, N.2
Coldman, A.J.3
-
90
-
-
0025800331
-
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
-
Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-170.
-
(1991)
N Engl J Med
, vol.325
, pp. 164-170
-
-
Crawford, J.1
Ozer, H.2
Stoller, R.3
-
91
-
-
79957940921
-
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: Results from the SALUTE trial
-
Spigel DR, Townley PM, Waterhouse DM, et al. Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial. J Clin Oncol 2011;29:2215-2222.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2215-2222
-
-
Spigel, D.R.1
Townley, P.M.2
Waterhouse, D.M.3
-
92
-
-
74249115314
-
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer
-
Spigel DR, Greco FA, Zubkus JD, et al. Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer. J Thorac Oncol 2009;4:1555-1560.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 1555-1560
-
-
Spigel, D.R.1
Greco, F.A.2
Zubkus, J.D.3
-
93
-
-
73349099070
-
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group study E3501
-
Horn L, Dahlberg SE, Sandler AB, et al. Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group study E3501. J Clin Oncol 2009;27:6006-6011.
-
(2009)
J Clin Oncol
, vol.27
, pp. 6006-6011
-
-
Horn, L.1
Dahlberg, S.E.2
Sandler, A.B.3
-
94
-
-
0347499622
-
Management of lung cancer in older adults
-
Hurria A, Kris MG. Management of lung cancer in older adults. CA Cancer J Clin 2003;53:325-341.
-
(2003)
CA Cancer J Clin
, vol.53
, pp. 325-341
-
-
Hurria, A.1
Kris, M.G.2
-
95
-
-
0030608237
-
Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: A stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party
-
Girling DJ. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party. Lancet 1996;348:563-566.
-
(1996)
Lancet
, vol.348
, pp. 563-566
-
-
Girling, D.J.1
-
96
-
-
0030946011
-
Five-day oral etoposide treatment for advanced small-cell lung cancer: Randomized comparison with intravenous chemotherapy
-
Souhami RL, Spiro SG, Rudd RM, et al. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst 1997;89:577-580.
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 577-580
-
-
Souhami, R.L.1
Spiro, S.G.2
Rudd, R.M.3
-
97
-
-
3042826879
-
Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with eastern cooperative oncology group performance status of 2, or age >= 70 years
-
Neubauer M, Schwartz J, Caracandas J, et al. Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with eastern cooperative oncology group performance status of 2, or age >= 70 years. J Clin Oncol 2004;22:1872-1877.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1872-1877
-
-
Neubauer, M.1
Schwartz, J.2
Caracandas, J.3
-
98
-
-
0031803819
-
New combination of the old drugs for elderly patients with small-cell lung cancer: A phase II study of the PAVE regimen
-
Westeel V, Murray N, Gelmon K, et al. New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen. J Clin Oncol 1998;16:1940-1947.
-
(1998)
J Clin Oncol
, vol.16
, pp. 1940-1947
-
-
Westeel, V.1
Murray, N.2
Gelmon, K.3
-
99
-
-
0032703877
-
Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer
-
Okamoto H, Watanabe K, Nishiwaki Y, et al. Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. J Clin Oncol 1999;17:3540-3545.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3540-3545
-
-
Okamoto, H.1
Watanabe, K.2
Nishiwaki, Y.3
-
100
-
-
0034866074
-
Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer
-
Matsui K, Masuda N, Yana T, et al. Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer. Intern Med 2001;40:603-606.
-
(2001)
Intern Med
, vol.40
, pp. 603-606
-
-
Matsui, K.1
Masuda, N.2
Yana, T.3
-
101
-
-
0031726506
-
Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer
-
Murray N, Grafton C, Shah A, et al. Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer. J Clin Oncol 1998;16:3323-3328.
-
(1998)
J Clin Oncol
, vol.16
, pp. 3323-3328
-
-
Murray, N.1
Grafton, C.2
Shah, A.3
-
102
-
-
73349141727
-
New advances in the second-line treatment of small cell lung cancer
-
Hurwitz JL, McCoy F, Scullin P, Fennell DA. New advances in the second-line treatment of small cell lung cancer. Oncologist 2009;14:986-994.
-
(2009)
Oncologist
, vol.14
, pp. 986-994
-
-
Hurwitz, J.L.1
McCoy, F.2
Scullin, P.3
Fennell, D.A.4
-
103
-
-
41749087812
-
Management of recurrent small cell lung cancer
-
Schneider BJ. Management of recurrent small cell lung cancer. J Natl Compr Canc Netw 2008;6:323-331.
-
(2008)
J Natl Compr Canc Netw
, vol.6
, pp. 323-331
-
-
Schneider, B.J.1
-
104
-
-
84857073822
-
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker
-
Pietanza MC, Kadota K, Huberman K, et al. Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker. Clin Cancer Res 2012;18:1138-1145.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 1138-1145
-
-
Pietanza, M.C.1
Kadota, K.2
Huberman, K.3
-
105
-
-
34247850949
-
Chemotherapy for relapsed small cell lung cancer: A systematic review and practice guideline
-
Cheng S, Evans WK, Stys-Norman D, Shepherd FA. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol 2007;2:348-354.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 348-354
-
-
Cheng, S.1
Evans, W.K.2
Stys-Norman, D.3
Shepherd, F.A.4
-
106
-
-
0034909054
-
New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer
-
Ettinger DS. New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer. Semin Oncol 2001;28:27-29.
-
(2001)
Semin Oncol
, vol.28
, pp. 27-29
-
-
Ettinger, D.S.1
-
107
-
-
0033996043
-
New chemotherapy agents for small cell lung cancer
-
Kelly K. New chemotherapy agents for small cell lung cancer. Chest 2000;117:156S-162S.
-
(2000)
Chest
, vol.117
-
-
Kelly, K.1
-
108
-
-
0037504528
-
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group trial 1597
-
Masters GA, Declerck L, Blanke C, et al. Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group trial 1597. J Clin Oncol 2003;21:1550-1555.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1550-1555
-
-
Masters, G.A.1
Declerck, L.2
Blanke, C.3
-
109
-
-
0033044111
-
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer
-
von Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 1999;17:658-667.
-
(1999)
J Clin Oncol
, vol.17
, pp. 658-667
-
-
Von Pawel, J.1
Schiller, J.H.2
Shepherd, F.A.3
-
110
-
-
34247218552
-
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
-
O'Brien ME, Ciuleanu TE, Tsekov H, et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 2006;24:5441-5447.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5441-5447
-
-
O'Brien, M.E.1
Ciuleanu, T.E.2
Tsekov, H.3
-
111
-
-
34249941781
-
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer
-
Eckardt JR, von Pawel J, Pujol JL, et al. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. J Clin Oncol 2007;25:2086-2092.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2086-2092
-
-
Eckardt, J.R.1
Von Pawel, J.2
Pujol, J.L.3
-
112
-
-
33750185826
-
Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
-
Huber RM, Reck M, Gosse H, et al. Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer. Eur Respir J 2006;27:1183-1189.
-
(2006)
Eur Respir J
, vol.27
, pp. 1183-1189
-
-
Huber, R.M.1
Reck, M.2
Gosse, H.3
-
113
-
-
34249735284
-
A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer
-
Shah C, Ready N, Perry M, et al. A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer. Lung Cancer 2007;57:84-88.
-
(2007)
Lung Cancer
, vol.57
, pp. 84-88
-
-
Shah, C.1
Ready, N.2
Perry, M.3
-
114
-
-
33846442125
-
Topotecan: Weekly intravenous (IV) schedule similar to standard 5-day IV schedule as second-line therapy for relapsed small cell lung cancer (SCLC)-A Minnie Pearl Cancer Research Network phase II trial [abstract]
-
Abstract 7083
-
Shipley DL, Hainsworth JD, Spigel DR, et al. Topotecan: weekly intravenous (IV) schedule similar to standard 5-day IV schedule as second-line therapy for relapsed small cell lung cancer (SCLC)-a Minnie Pearl Cancer Research Network phase II trial [abstract]. J Clin Oncol 2006;24(Suppl 18):Abstract 7083.
-
(2006)
J Clin Oncol
, vol.24
, Issue.SUPPL. 18
-
-
Shipley, D.L.1
Hainsworth, J.D.2
Spigel, D.R.3
-
115
-
-
77956396425
-
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer
-
Ettinger DS, Jotte R, Lorigan P, et al. Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer. J Clin Oncol 2010;28:2598-2603.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2598-2603
-
-
Ettinger, D.S.1
Jotte, R.2
Lorigan, P.3
-
116
-
-
56749131841
-
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402
-
Inoue A, Sugawara S, Yamazaki K, et al. Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402. J Clin Oncol 2008;26:5401-5406.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5401-5406
-
-
Inoue, A.1
Sugawara, S.2
Yamazaki, K.3
-
117
-
-
34247197121
-
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301
-
Onoda S, Masuda N, Seto T, et al. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol 2006;24:5448-5453.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5448-5453
-
-
Onoda, S.1
Masuda, N.2
Seto, T.3
-
118
-
-
60649090249
-
Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer
-
Shimokawa T, Shibuya M, Kitamura K, et al. Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer. Int J Clin Oncol 2009;14:63-69.
-
(2009)
Int J Clin Oncol
, vol.14
, pp. 63-69
-
-
Shimokawa, T.1
Shibuya, M.2
Kitamura, K.3
-
119
-
-
79951993031
-
Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy
-
Jotte R, Conkling P, Reynolds C, et al. Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy. J Clin Oncol 2011;29:287-293.
-
(2011)
J Clin Oncol
, vol.29
, pp. 287-293
-
-
Jotte, R.1
Conkling, P.2
Reynolds, C.3
-
120
-
-
2442617202
-
70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: Analysis of Cancer and Leukemia Group B study 39808
-
Bogart JA, Herndon JE II, Lyss AP, et al. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808. Int J Radiat Oncol Biol Phys 2004;59:460-468.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 460-468
-
-
Bogart, J.A.1
Herndon, J.E.I.I.2
Lyss, A.P.3
-
121
-
-
0028357990
-
Limited-stage small-cell lung cancer: Patterns of intrathoracic recurrence and the implications for thoracic radiotherapy
-
Liengswangwong V, Bonner JA, Shaw EG, et al. Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol 1994;12:496-502.
-
(1994)
J Clin Oncol
, vol.12
, pp. 496-502
-
-
Liengswangwong, V.1
Bonner, J.A.2
Shaw, E.G.3
-
122
-
-
20144388394
-
Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer
-
Kim TH, Cho KH, Pyo HR, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 2005;235:208-215.
-
(2005)
Radiology
, vol.235
, pp. 208-215
-
-
Kim, T.H.1
Cho, K.H.2
Pyo, H.R.3
-
123
-
-
65749102667
-
Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy
-
Rose J, Rodrigues G, Yaremko B, et al. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 2009;91:282-287.
-
(2009)
Radiother Oncol
, vol.91
, pp. 282-287
-
-
Rose, J.1
Rodrigues, G.2
Yaremko, B.3
-
124
-
-
81855206076
-
Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus
-
Kong FM, Ritter T, Quint DJ, et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 2011;81:1442-1457.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 1442-1457
-
-
Kong, F.M.1
Ritter, T.2
Quint, D.J.3
-
125
-
-
83955161774
-
Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer
-
Shirvani SM, Komaki R, Heymach JV, et al. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012;82:e91-97.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
-
-
Shirvani, S.M.1
Komaki, R.2
Heymach, J.V.3
-
126
-
-
0033016449
-
Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study
-
Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 1999;17:2092-2099.
-
(1999)
J Clin Oncol
, vol.17
, pp. 2092-2099
-
-
Jeremic, B.1
Shibamoto, Y.2
Nikolic, N.3
-
127
-
-
0028910241
-
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
-
Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995;87:183-190.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 183-190
-
-
Arriagada, R.1
Le Chevalier, T.2
Borie, F.3
-
128
-
-
0345062339
-
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group
-
Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-484.
-
(1999)
N Engl J Med
, vol.341
, pp. 476-484
-
-
Auperin, A.1
Arriagada, R.2
Pignon, J.P.3
-
129
-
-
34547937885
-
Prophylactic cranial irradiation in extensive small-cell lung cancer
-
Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-672.
-
(2007)
N Engl J Med
, vol.357
, pp. 664-672
-
-
Slotman, B.1
Faivre-Finn, C.2
Kramer, G.3
-
130
-
-
77955358817
-
Cognitive sparing during the administration of whole brain radiotherapy and prophylactic cranial irradiation: Current concepts and approaches
-
Marsh JC, Gielda BT, Herskovic AM, Abrams RA. Cognitive sparing during the administration of whole brain radiotherapy and prophylactic cranial irradiation: current concepts and approaches. J Oncol 2010;2010:198-208.
-
(2010)
J Oncol
, vol.2010
, pp. 198-208
-
-
Marsh, J.C.1
Gielda, B.T.2
Herskovic, A.M.3
Abrams, R.A.4
-
131
-
-
79951936926
-
Radiotherapy in small-cell lung cancer: Lessons learned and future directions
-
Slotman BJ, Senan S. Radiotherapy in small-cell lung cancer: lessons learned and future directions. Int J Radiat Oncol Biol Phys 2011;79:998-1003.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.79
, pp. 998-1003
-
-
Slotman, B.J.1
Senan, S.2
-
132
-
-
65449145578
-
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): A randomised clinical trial
-
Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 2009;10:467-474.
-
(2009)
Lancet Oncol
, vol.10
, pp. 467-474
-
-
Le Pechoux, C.1
Dunant, A.2
Senan, S.3
-
133
-
-
79961127734
-
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer
-
Wolfson AH, Bae K, Komaki R, et al. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81:77-84.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 77-84
-
-
Wolfson, A.H.1
Bae, K.2
Komaki, R.3
-
134
-
-
58149346191
-
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: Short-term health-related quality of life and patient reported symptoms-results of an international phase III randomized controlled trial by the EORTC radiation oncology and lung cancer groups
-
Slotman BJ, Mauer ME, Bottomley A, et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms-results of an international phase III randomized controlled trial by the EORTC radiation oncology and lung cancer groups. J Clin Oncol 2009;27:78-84.
-
(2009)
J Clin Oncol
, vol.27
, pp. 78-84
-
-
Slotman, B.J.1
Mauer, M.E.2
Bottomley, A.3
-
135
-
-
70350757850
-
8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: Results of a phase III randomized multicentre Italian trial
-
Maranzano E, Trippa F, Casale M, et al. 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 2009;93:174-179.
-
(2009)
Radiother Oncol
, vol.93
, pp. 174-179
-
-
Maranzano, E.1
Trippa, F.2
Casale, M.3
-
136
-
-
79951956249
-
Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline
-
Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;79:965-976.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.79
, pp. 965-976
-
-
Lutz, S.1
Berk, L.2
Chang, E.3
-
138
-
-
84865179740
-
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
-
Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 2012;4:CD003869.
-
(2012)
Cochrane Database Syst Rev
, vol.4
-
-
Tsao, M.N.1
Lloyd, N.2
Wong, R.K.3
-
139
-
-
0028797891
-
Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years
-
Johnson BE, Linnoila RI, Williams JP, et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol 1995;13:101-111.
-
(1995)
J Clin Oncol
, vol.13
, pp. 101-111
-
-
Johnson, B.E.1
Linnoila, R.I.2
Williams, J.P.3
-
140
-
-
0032538039
-
Second lung cancers in patients after treatment for an initial lung cancer
-
Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998;90:1335-1345.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1335-1345
-
-
Johnson, B.E.1
-
141
-
-
0027438775
-
Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers
-
Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383-390.
-
(1993)
Ann Intern Med
, vol.119
, pp. 383-390
-
-
Richardson, G.E.1
Tucker, M.A.2
Venzon, D.J.3
-
142
-
-
7344228962
-
Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation
-
Kawahara M, Ushijima S, Kamimori T, et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer 1998;78:409-412.
-
(1998)
Br J Cancer
, vol.78
, pp. 409-412
-
-
Kawahara, M.1
Ushijima, S.2
Kamimori, T.3
-
143
-
-
75749108918
-
Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis
-
Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.
-
(2010)
BMJ
, vol.340
-
-
Parsons, A.1
Daley, A.2
Begh, R.3
Aveyard, P.4
|